Cargando…
Inducible MLL-AF9 Expression Drives an AML Program during Human Pluripotent Stem Cell-Derived Hematopoietic Differentiation
A t(9;11)(p22;q23) translocation produces the MLL-AF9 fusion protein, which is found in up to 25% of de novo AML cases in children. Despite major advances, obtaining a comprehensive understanding of context-dependent MLL-AF9-mediated gene programs during early hematopoiesis is challenging. Here, we...
Autores principales: | Heuts, Branco M. H., Arza-Apalategi, Saioa, Alkema, Sinne G., Tijchon, Esther, Jussen, Laura, Bergevoet, Saskia M., van der Reijden, Bert A., Martens, Joost H. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136707/ https://www.ncbi.nlm.nih.gov/pubmed/37190104 http://dx.doi.org/10.3390/cells12081195 |
Ejemplares similares
-
Identification of transcription factors dictating blood cell development using a bidirectional transcription network-based computational framework
por: Heuts, B. M. H., et al.
Publicado: (2022) -
MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in 11q23 acute myeloid leukemia
por: Prange, K H M, et al.
Publicado: (2017) -
Reprogramming of MLL-AF9 leukemia cells into pluripotent stem cells
por: Liu, Y, et al.
Publicado: (2014) -
Protocol to establish a stable MLL-AF9_AML mouse model
por: Lu, Jun, et al.
Publicado: (2022) -
The acute myeloid leukemia associated AML1-ETO fusion protein alters the transcriptome and cellular progression in a single-oncogene expressing in vitro induced pluripotent stem cell based granulocyte differentiation model
por: Tijchon, Esther, et al.
Publicado: (2019)